Enzymotec Granted Patent for Omega-Sterols in Australia
Omega-sterols were clinically proven to be effective for blood lipid control, and efficient in supporting healthy levels of both blood triglycerides and LDL-cholesterol (bad cholesterol) in humans.
Dec 14 2011 --- Enzymotec patent for Omega-Sterols (No. AU-0552025002) was granted by the Australian patent office.
Omega-sterols is a unique ingredient manufactured by Enzymotec Ltd. This ingredient is composed of naturally occurring hybrids of phytosterol and omega 3. Omega-sterols were clinically proven to be effective for blood lipid control, and efficient in supporting healthy levels of both blood triglycerides and LDL-cholesterol (bad cholesterol) in humans.
“This product and its patent applications are an essential part of our strategy to lead the market through innovation and to provide a clear edge to our customers", says Dr. Eyal Afergan Omega-3 category Manager for Enzymotec
“The patent refers to the use of Omega-SterolsTM as a functional food for diabetics and is part of five different patents that cover the various properties, composition and methods of use for this product.” Says Dr. Sigalit Zchut, Director of R&D. “Omega sterols were also clinically proven to be better than standard sterol-esters since they do not hinder the absorption of certain vitamins, such as Vitamin E. Additionally, there is an initial indication that Omega-Sterols may reduce CRP levels and blood pressure as-well”, concluded Dr. Zchut.
Enzymotec, a dynamic biotech company and a leading global developer, is a manufacturer and supplier of lipid-based products and solutions.
Enzymotec develops, produces and markets innovative BioActive ingredients and finished products based on sophisticated proprietary technologies. Enzymotec's products support general health, from cardiovascular to cognitive functions, in the largest therapeutic markets and deliver innovative solutions in three business segments:
1) VAYA Pharma – a research-based, specialty pharmaceutical division, dedicated to the discovery, development, manufacture and marketing of innovative, clinically tested, effective and safe lipids based medicines.
2) Infant Nutrition -Providing lipid compositions that mimic the fat in human milk for the wellbeing of infants
3) BioActive Ingredients – Providing premium innovative bioactive ingredients tailored to suit unique needs of pharmaceutical and nutrition industries.
